The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
17 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,160,204 in first-year total cost, median $247,541.
Most frequent study sections
- Special Emphasis Panel[ZRG1 OBT-J (55)]6
- Special Emphasis Panel[ZRG1 BTC-J (55)]3
- Special Emphasis Panel[ZRG1 BTC-Y (55)]3
- Special Emphasis Panel[ZRG1 OBT-D (55)]3
- Special Emphasis Panel[ZRG1 BTC-M (55)]2
Most frequent institutions
- DUKE UNIVERSITY1
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH1
- GEORGE MASON UNIVERSITY1
- H. LEE MOFFITT CANCER CTR & RES INST1
- MAYO CLINIC JACKSONVILLE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Development of integrated risk models of genetic and non-genetic risk factors in endometrial cancer across diverse ancestries1R21CA294233-01 | CHAMBWE, NYASHA | FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, NY | $456,103 | ZRG1 |
| 2024 | The role of long noncoding RNAs in acute myeloid leukemia1R21CA270067-01A1 | TRINH, BON Q | UNIVERSITY OF VIRGINIA, VA | $415,259 | ZRG1 |
| 2024 | Evaluating the role of SPAK and OSR1 kinases in glioblastoma chemotherapy resistance1R21CA284153-01A1 | SCHIAPPARELLI, PAULA V | MAYO CLINIC JACKSONVILLE, FL | $402,401 | ZRG1 |
| 2024 | The Role of Platelets in Cancer Cachexia1R21CA289464-01 | VELAZQUEZ, KANDY T | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $204,391 | ZRG1 |
| 2023 | Germline Genetic Modifiers of Radiation Response1R21CA274598-01A1 | MCDONALD, JOHN TYSON | SRI INTERNATIONAL, CA | $401,125 | ZRG1 |
| 2023 | The role of extracellular matrix quality in the prediction of metastasis-induced skeletal fragility and response to immunotherapy1R21CA284159-01 | BAILEY, STACYANN R | UNIVERSITY OF MASSACHUSETTS AMHERST, MA | $392,617 | ZRG1 |
| 2023 | Mechanisms of lipid droplet trafficking in hepatocellular carcinoma1R21CA279878-01 | SCHOTT, MICAH | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $215,284 | ZRG1 |
| 2023 | Secretory Mitophagy in Cancer Metabolic Reprogramming1R21CA284201-01 | HOWARD, MARISSA ASHTON | GEORGE MASON UNIVERSITY, VA | $204,502 | ZRG1 |
| 2022 | Exploiting Epigenetic Vulnerabilities In Glioblastoma Stem Cells Through Reprogramming1R21CA264635-01A1 | ETAME, ARNOLD | H. LEE MOFFITT CANCER CTR & RES INST, FL | $433,257 | ZRG1 |
| 2022 | Regulation of Melanoma Cell Malignancy by Compartmentalized Chemokine Receptor Signaling1R21CA243052-01A1 | THOMSEN, ALEX ROJAS BIE | NEW YORK UNIVERSITY, NY | $412,686 | ZRG1 |
| 2022 | Mechanistic study of Hedgehog signaling in the cilium1R21CA274595-01 | GE, XUECAI | UNIVERSITY OF CALIFORNIA, MERCED, CA | $384,752 | ZRG1 |
| 2022 | The role of NPM1 in preserving a hematopoietic stem cell identity1R21CA264575-01A1 | ESCOBAR, THELMA | UNIVERSITY OF WASHINGTON, WA | $247,541 | ZRG1 |
| 2022 | Role of extracellular matrix remodeling on high-grade serous ovarian carcinoma immune evasion1R21CA259158-01A1 | DE LA PUENTE, PILAR | SANFORD RESEARCH/USD, SD | $232,815 | ZRG1 |
| 2022 | Characterization of endovascular ablative therapies with computational modeling1R21CA260016-01A1 | FUENTES, DAVID | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $227,205 | ZRG1 |
| 2022 | Targeting invasive plasticity by inhibiting mitochondrial adaptations to matrix metalloproteinase loss1R21CA264632-01A1 | KELLEY, LAURA CATHERINE | DUKE UNIVERSITY, NC | $225,803 | ZRG1 |
| 2022 | The role of tumor endothelium-specific prion-gene PRND in epithelial ovarian cancer1R21CA264627-01A1 | AL-HILAL, TASLIM A | UNIVERSITY OF TEXAS EL PASO, TX | $213,283 | ZRG1 |
| 2022 | Centromeres and Ovarian Cancer1R21CA259630-01A1 | CONTRERAS, RAFAEL ALEJANDRO | UNIVERSITY OF MINNESOTA, MN | $91,180 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.